medRxiv : the preprint server for health sciences · 2025
Natural history and impact of Giardia lamblia on child growth attainment and associated pathway-specific biomarkers in a Nicaraguan birth cohort.
СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gutiérrez Lester, Vielot Nadja A, Reyes Yaoska, Herrera Roberto, Toval-Ruiz Christian, Mora Javier, Arndt Michael B, Barney Rebecca, Choy Robert Km, Bucardo Filemón, Vilchez Samuel, Becker-Dreps Sylvia, Bartelt Luther A
Аннотация
BACKGROUND: Giardia lamblia (Giardia) is one of the most common intestinal parasitic infections globally, with an estimated 280 million symptomatic infections annually. In children from low- and middle-income countries (LMICs), Giardia is highly prevalent and has been associated with loss of intestinal barrier function, nutrient-metabolic dysregulation, and linear growth impairment, but specific mechanisms linking Giardia to these outcomes remain poorly understood.
METHODS AND RESULTS: We used data and samples from a subset of 76 children in a longitudinal birth cohort in Nicaragua to evaluate the natural history and geospatial distribution of Giardia infections, child growth outcomes (weight-for-age [WAZ] and length-for-age [LAZ] z scores), and relationships with established biomarkers of inflammation, intestinal damage, and growth-signaling. During the first 36 months of life, we tested 2,305 stools (1,903 surveillance stools and 402 diarrheal stools) for Giardia by qPCR. The incidence of Giardia-positive stools was 59.6 per 100 child-years. Any detection of Giardia was associated with a reduction in LAZ at 36 months of life (β:-0.16, P=0.042). This effect increased when considering persistent or recurrent Giardia detections (β:-0.26, P=<0.001) as well as living in a high-density Giardia detection area (β:-0.44, P=<0.001). Among intestinal markers, Giardia was only associated with lower median fecal neopterin (a marker of chronic intestinal T cell activation) at 24 and 36 months of age. Among serum systemic biomarkers measured at 24 months, Giardia detections were associated with indicators of intestinal epithelial cell damage (higher median Intestinal Fatty Acid Binding Protein (P=0.002) and Anti-FliC IgA (P=0.033), and reduced growth-signaling hormone (lower median Insulin-like Growth Factor (IGF-1) (P=0.005).
CONCLUSION: Giardia detection was negatively associated with linear growth in an exposure-dependent manner. Simultaneously, Giardia associates with diminished serum growth-signaling hormones. Patterns of serum and fecal intestinal biomarkers suggest that Giardia-mediated epithelial disruption is dissociated from markers of intestinal inflammation.
METHODS AND RESULTS: We used data and samples from a subset of 76 children in a longitudinal birth cohort in Nicaragua to evaluate the natural history and geospatial distribution of Giardia infections, child growth outcomes (weight-for-age [WAZ] and length-for-age [LAZ] z scores), and relationships with established biomarkers of inflammation, intestinal damage, and growth-signaling. During the first 36 months of life, we tested 2,305 stools (1,903 surveillance stools and 402 diarrheal stools) for Giardia by qPCR. The incidence of Giardia-positive stools was 59.6 per 100 child-years. Any detection of Giardia was associated with a reduction in LAZ at 36 months of life (β:-0.16, P=0.042). This effect increased when considering persistent or recurrent Giardia detections (β:-0.26, P=<0.001) as well as living in a high-density Giardia detection area (β:-0.44, P=<0.001). Among intestinal markers, Giardia was only associated with lower median fecal neopterin (a marker of chronic intestinal T cell activation) at 24 and 36 months of age. Among serum systemic biomarkers measured at 24 months, Giardia detections were associated with indicators of intestinal epithelial cell damage (higher median Intestinal Fatty Acid Binding Protein (P=0.002) and Anti-FliC IgA (P=0.033), and reduced growth-signaling hormone (lower median Insulin-like Growth Factor (IGF-1) (P=0.005).
CONCLUSION: Giardia detection was negatively associated with linear growth in an exposure-dependent manner. Simultaneously, Giardia associates with diminished serum growth-signaling hormones. Patterns of serum and fecal intestinal biomarkers suggest that Giardia-mediated epithelial disruption is dissociated from markers of intestinal inflammation.